JP2000327525A - Skin preparation for external use - Google Patents

Skin preparation for external use

Info

Publication number
JP2000327525A
JP2000327525A JP11139207A JP13920799A JP2000327525A JP 2000327525 A JP2000327525 A JP 2000327525A JP 11139207 A JP11139207 A JP 11139207A JP 13920799 A JP13920799 A JP 13920799A JP 2000327525 A JP2000327525 A JP 2000327525A
Authority
JP
Japan
Prior art keywords
extract
derivatives
skin
acid
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11139207A
Other languages
Japanese (ja)
Inventor
Tomonori Hata
友紀 畑
Hiroshi Hoshino
拓 星野
Shizuka Uehara
静香 上原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP11139207A priority Critical patent/JP2000327525A/en
Publication of JP2000327525A publication Critical patent/JP2000327525A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a skin preparation for external use, having excellent activities for preventing the skin from being aged, and capable of imparting tenseness and gloss to the skin by including an extract of Myrciaria dubia, and a cell- activating agent. SOLUTION: This skin preparation for external use contains an extract of Myrciaria dubia, and a cell-activating agent. The content of the cell-activating agent is 0.0001-5 wt.% expressed in terms of dried solid, and the content of the included extract of the Myrciaria dubia is 0.0001-5 wt.% expressed in terms of the dried solid.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、皮膚外用剤に関
し、更に詳細には、カムカム抽出物と細胞賦活剤を含有
することにより、優れた皮膚老化防止や肌にはりやつや
を与えることができる皮膚外用剤に関する。
TECHNICAL FIELD The present invention relates to an external preparation for skin, and more particularly, to an excellent preparation for preventing skin aging and imparting a shine to the skin by containing a cam cam extract and a cell activator. It relates to a skin external preparation.

【0002】[0002]

【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、分散液、洗浄料、軟膏、分散液、外用液剤等の皮
膚外用剤には、皮膚の老化防止や肌にはりやつやを与え
ることを目的として細胞賦活剤などの薬効成分が加えら
れている。例えば、皮膚老化防止、細胞賦活を目的に、
ニンジン抽出物、牛血液除蛋白抽出物、ビフィズス菌発
酵代謝産物等の薬効成分が配合されている。
2. Description of the Related Art Conventionally, skin external preparations such as emulsions, creams, lotions, packs, dispersions, detergents, ointments, dispersions, and external preparations have been used to prevent aging of the skin and give the skin a luster. For that purpose, medicinal ingredients such as cell activators have been added. For example, for the purpose of skin aging prevention, cell activation,
Pharmaceutical ingredients such as carrot extract, bovine blood deproteinizing extract, and bifidobacterium fermentation metabolite are incorporated.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、これら
の細胞賦活剤を配合した皮膚外用剤では、薬効成分の効
果が十分でなかったり、あるいは、薬効を得るのに十分
な量を配合すると安定性に欠けたり使用感が損なわれる
等、その改善が望まれていた。
However, external preparations for skin containing these cell activators do not have sufficient effects of the medicinal components or, if they are added in a sufficient amount to obtain the medicinal effects, the stability will be degraded. Improvements such as chipping or impaired usability have been desired.

【0004】[0004]

【課題を解決するための手段】本発明者らは、皮膚外用
剤に老化防止や肌にはりやつやを与えることを目的とし
て加えられた細胞賦活剤の効果を向上させるべく鋭意検
討を行った結果、カムカム抽出物と細胞賦活剤とを組み
合わせれば、本来細胞賦活剤が有する作用が十分発揮さ
れることを見出し、本発明を完成した。すなわち、本発
明は、カムカム抽出物と細胞賦活剤を含有する皮膚外用
剤を提供するものである。
Means for Solving the Problems The present inventors have made intensive studies to improve the effect of a cell activator added to an external preparation for the purpose of preventing aging and giving the skin a shine. As a result, it has been found that when the camcam extract is combined with the cell activator, the action originally possessed by the cell activator is sufficiently exhibited, and the present invention has been completed. That is, the present invention provides a skin external preparation containing a camcam extract and a cell activator.

【0005】[0005]

【発明の実施の形態】本発明の(A)成分であるカムカ
ム抽出物は、フトモモ科に属する植物であるカムカム
(学名Myrciaria Dubia)の果実から、
抽出溶媒を用いて抽出する。その調製法は特に限定され
ないが、例えば種々の適当な溶媒を用いて低温もしくは
室温〜加温下で抽出される。
BEST MODE FOR CARRYING OUT THE INVENTION The cam cam extract, which is the component (A) of the present invention, is obtained from the fruit of a cam cam (scientific name Myrcilia Dubia), a plant belonging to the family Myrtaceae.
Extract using an extraction solvent. The preparation method is not particularly limited, but, for example, extraction is performed at low temperature or at room temperature to heating using various suitable solvents.

【0006】抽出溶媒としては、例えば水;メチルアル
コール、エチルアルコール等の低級1価アルコール;グ
リセリン、プロピレングリコール、1,3−ブチレング
リコール等の液状多価アルコール等の1種または2種以
上を用いることができる。好ましい抽出方法の例として
は、含水濃度20〜90% (v/v)のエチルアルコ
ールを用い、低温にて2〜3日間抽出を行ったのち濾過
し、得られた濾液をさらに5日間ほど放置して熟成さ
せ、再び濾過を行う方法が挙げられる。
As the extraction solvent, for example, one or more of water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; and liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol are used. be able to. As an example of a preferred extraction method, extraction is performed at a low temperature for 2 to 3 days using ethyl alcohol having a water content of 20 to 90% (v / v), followed by filtration, and the obtained filtrate is left for about 5 days. And then aging and filtering again.

【0007】本発明の(A)成分であるカムカム抽出物
の含有量は、乾燥固形分として0.0001〜5重量%
(以下単に「%」で示す)が好ましく、より好ましくは
0.001〜3%である。カムカム抽出物の含有量がこ
の範囲であると、本発明の効果がより良く発現する。
The content of the cam cam extract, which is the component (A) of the present invention, is 0.0001 to 5% by weight as dry solids.
(Hereinafter simply referred to as “%”), more preferably 0.001 to 3%. When the content of the camu cam extract is in this range, the effects of the present invention are better exhibited.

【0008】本発明の(B)成分である細胞賦活剤は好
ましいものとして、以下に示すものが挙げられる。
The cell activator which is the component (B) of the present invention is preferably as follows.

【0009】細胞賦活剤の好ましいものとして、ブドウ
種子油、デオキシリボ核酸及びその誘導体、アデノシン
三リン酸、アデノシン一リン酸などのアデニル酸誘導
体、リボ核酸及びその誘導体、サイクリックAMP、サ
イクリックGMP、フラビンアデニンジヌクレオチド、
グアニン、アデニン、シトシン、チミン、キサンチン及
びその誘導体、レチノール及びその誘導体(パルミチン
酸レチノール、酢酸レチノール等)、レチナール及びそ
の誘導体、デヒドロレチナール、カロチン等のカロチノ
イド等のビタミンA類、チアミン類(チアミン塩酸塩、
チアミン硫酸塩)、リボフラビン類(リボフラビン、酢
酸リボフラビン等)、ピリドキシン類(塩酸ピリドキシ
ン、ピリドキシンジオクタノエート等)、シアノコバラ
ミン、葉酸類、ニコチン酸類(ニコチン酸アミド、ニコ
チン酸ベンジル等)、コリン類等のビタミンB類、アス
コルビン酸及びその誘導体等のビタミンC類、α−及び
γ−リノレン酸及びそれらの誘導体、エイコサペンタエ
ン酸及びその誘導体、エストラジオール及びその誘導
体、グリコール酸、コハク酸、乳酸、サリチル酸等の有
機酸及びそれらの誘導体等が挙げられ、これらの一種又
は二種以上を適宜選択して加えることができる。なお、
これらの「誘導体」においては形成可能な塩も含まれ
る。
Preferred cell activators include grape seed oil, deoxyribonucleic acid and its derivatives, adenylic acid derivatives such as adenosine triphosphate and adenosine monophosphate, ribonucleic acid and its derivatives, cyclic AMP, cyclic GMP, Flavin adenine dinucleotide,
Vitamin A such as carotenoids such as guanine, adenine, cytosine, thymine, xanthine and derivatives thereof, retinol and derivatives thereof (retinol palmitate, retinol acetate, etc.), retinal and derivatives thereof, dehydroretinal and carotene; thiamines (thiamine hydrochloride salt,
Thiamine sulfate), riboflavins (riboflavin, riboflavin acetate, etc.), pyridoxines (pyridoxine hydrochloride, pyridoxine dioctanoate, etc.), cyanocobalamins, folic acids, nicotinic acids (nicotinamide, benzyl nicotinate, etc.), cholines, etc. Vitamin Cs such as vitamin Bs, ascorbic acid and its derivatives, α- and γ-linolenic acid and their derivatives, eicosapentaenoic acid and its derivatives, estradiol and its derivatives, glycolic acid, succinic acid, lactic acid, salicylic acid, etc. And one or more of these can be appropriately selected and added. In addition,
These “derivatives” include salts that can be formed.

【0010】これら細胞賦活剤のうち、特に好ましいも
のとしては、アデノシン三リン酸及びその誘導体、エス
トラジオール及びその誘導体、レチナール及びその誘導
体、パルミチン酸レチノール、乳酸、コハク酸及びそれ
らの誘導体が挙げられる。
Among these cell activators, particularly preferred are adenosine triphosphate and its derivatives, estradiol and its derivatives, retinal and its derivatives, retinol palmitate, lactic acid, succinic acid and their derivatives.

【0011】また細胞賦活剤として他に好ましいものと
して、ブタ、ウシ等の胎盤抽出物、幼牛血液抽出物、血
清除蛋白抽出物、脾臓抽出物、トリ等の卵成分、鶏冠抽
出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シル
クプロテイン及びその分解物又はそれらの誘導体、ヘモ
グロビン又はその分解物、ラクトフェリン又はその分解
物、イカスミ等の軟体動物抽出物、魚肉抽出物、酵母、
乳酸菌、ビフィズス菌等の発酵代謝産物、アスパラガス
抽出物、アンズ抽出物、イチョウ抽出物、オオムギ抽出
物、オウバク抽出物、オレンジ抽出物、キュウリ抽出
物、キウイ抽出物、シイタケ抽出物、スギナ抽出物、セ
ンブリ抽出物、ダイズ抽出物、タイソウ抽出物、トウキ
ンセンカ抽出物、トウガラシ抽出物、ニンニク抽出物、
ニンジン抽出物、ブクリョウ抽出物、ブナの芽抽出物、
モモ抽出物、レタス抽出物、レモン抽出物、ユーカリ抽
出物、ユリ球根抽出物、ローズマリー抽出物、ヒノキチ
オール、セファランチン、霊芝抽出物等が挙げられ、こ
れらの一種又は二種以上を適宜選択して加えることがで
きる。
Other preferred cell activators include placental extracts such as pigs and cows, calf blood extracts, serum deproteinized extracts, spleen extracts, egg components such as birds, cockscomb extracts, and shells. Extracts, shellfish extracts, royal jelly, silk protein and its degradation products or their derivatives, hemoglobin or its degradation products, lactoferrin or its degradation products, mollusc extracts such as squid, fish meat extracts, yeast,
Fermentation metabolites such as lactic acid bacteria, bifidobacteria, asparagus extract, apricot extract, ginkgo extract, barley extract, oak extract, orange extract, cucumber extract, kiwi extract, shiitake extract, and horsetail extract , Assembly extract, soybean extract, syrup extract, calendula extract, capsicum extract, garlic extract,
Carrot extract, liquorice extract, beech bud extract,
Peach extract, lettuce extract, lemon extract, eucalyptus extract, lily bulb extract, rosemary extract, hinokitiol, cepharanthin, ganoderma extract and the like, and one or more of these may be appropriately selected. Can be added.

【0012】これら細胞賦活剤のうち、特に好ましいも
のとしては、胎盤抽出物、貝肉抽出物、ニンジン抽出
物、乳酸菌発酵代謝産物、イチョウ抽出物、オオムギ抽
出物、オウバク抽出物、ダイズ抽出物、ブナの芽抽出物
が挙げられる。
Among these cell activators, particularly preferred are placenta extract, shellfish extract, carrot extract, lactic acid bacteria fermentation metabolite, ginkgo extract, barley extract, oak extract, soybean extract, Beech bud extract.

【0013】本発明における(B)成分の細胞賦活剤の
含有量は、0.0001〜5%が好ましく、より好まし
くは0.001〜3%である。抽出物の含有量は、乾燥
固形分として0.0001〜5%であり、好ましくは
0.001〜3%である。抽出液のまま用いる場合は乾
燥固形分としてこの範囲であれば、カムカム抽出物と組
み合わせた場合、製剤及び製剤中のカムカム抽出物に影
響を及ぼすことがなく、経時安定性も良好で、優れた細
胞賦活効果を発揮し、かつ、優れた使用感の皮膚外用剤
が得られる。
The content of the cell activator (B) in the present invention is preferably 0.0001 to 5%, more preferably 0.001 to 3%. The content of the extract is 0.0001 to 5%, preferably 0.001 to 3%, as a dry solid content. When the extract is used as it is, as long as it is in this range as a dry solid content, when combined with the camcam extract, it does not affect the formulation and the camcam extract in the formulation, and has good stability over time and is excellent. An external preparation for skin that exhibits a cell activating effect and has an excellent feeling upon use can be obtained.

【0014】本発明の皮膚外用剤は、常法に従い必須成
分である(A)成分と(B)成分とを通常の皮膚外用剤
として知られる種々の形態に調製することができる。
The external preparation for skin of the present invention can be prepared according to a conventional method from the essential components (A) and (B) into various forms known as ordinary external preparations for skin.

【0015】皮膚外用剤の形態としては、特に限定され
ず、例えば、乳液、クリーム、化粧水、パック、洗浄料
等のスキンケア化粧料、口紅、ファンデーション等のメ
ーキャップ化粧料、頭皮用化粧料や、軟膏、分散液、外
用液剤などの医薬品等とすることができその剤型につい
ても特に制限はなく、固型状、ペースト状、ムース状、
ジェル状、粉末状、溶液系、可溶化系、乳化系、粉末分
散系、多層状とすることができる。
The form of the external preparation for skin is not particularly limited, and examples thereof include skin care cosmetics such as milky lotions, creams, lotions, packs, cleaning agents, makeup cosmetics such as lipsticks and foundations, cosmetics for the scalp, and the like. Ointments, dispersions, pharmaceuticals such as topical liquids and the like can be used, and there is no particular limitation on the form of the preparation. Solid, paste, mousse,
Gel, powder, solution, solubilizing, emulsifying, powder dispersing and multi-layered can be used.

【0016】また、本発明の皮膚外用剤には、上記
(A)、(B)成分以外に、本発明の効果を損なわない
範囲で、通常、化粧料や医薬部外品、外用医薬品等の製
剤に使用される成分、すなわち、水、油剤、界面活性
剤、金属セッケン、ゲル化剤、粉体、アルコール類、水
溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、包接化
合物、抗菌剤、香料、消臭剤、塩類、PH調整剤、清涼
剤、動物・微生物由来抽出物、植物抽出物、血行促進
剤、収斂剤、抗脂漏剤、活性酸素消去剤、美白剤、抗炎
症剤、角質溶解剤、酵素、ホルモン類、ビタミン類等を
加えることができる。
In addition to the components (A) and (B), the external preparation for skin of the present invention usually contains cosmetics, quasi-drugs, and external medicines as long as the effects of the present invention are not impaired. Ingredients used in the formulation, i.e., water, oils, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble polymers, film-forming agents, resins, UV protection agents, clathrate compounds, antibacterial Agents, fragrances, deodorants, salts, pH regulators, cooling agents, animal / microbial extracts, plant extracts, blood circulation enhancers, astringents, antiseborrheic agents, active oxygen scavengers, whitening agents, anti-inflammatory Agents, keratolytic agents, enzymes, hormones, vitamins and the like.

【0017】[0017]

【実施例】次に参考例、試験例及び実施例、比較例を挙
げて本発明を更に詳細に説明するが、本発明はこれらに
なんら制約されるものではない。
EXAMPLES Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples, Examples and Comparative Examples, but the present invention is not limited thereto.

【0018】参考例1 カムカム抽出物の製造 カムカム(学名Myrciaria Dubia)の果
実を乾燥したもの30gに、含水濃度80%(v/v)
エチルアルコール100mlを加え、室温にて3日間抽
出を行った後、濾過してカムカム抽出物を得た(乾燥固
形分3.0%)。
REFERENCE EXAMPLE 1 Production of cam cam extract A 30 g portion of dried cam cam (Myrciaria Dubia) fruit was dried at a water content of 80% (v / v).
After adding 100 ml of ethyl alcohol and performing extraction at room temperature for 3 days, the resultant was filtered to obtain a cam cam extract (dry solid content: 3.0%).

【0019】参考例2 ニンジン抽出物の製造 ニンジンの根250gを細切し、無水エタノール1リッ
トルを加えてブレンダーを用いて一昼夜撹拌抽出し、ニ
ンジン抽出物を得た(乾燥固形分1.1%)。
REFERENCE EXAMPLE 2 Production of carrot extract Carrot root (250 g) was finely cut, 1 liter of absolute ethanol was added thereto, and the mixture was stirred and extracted for a day and night using a blender to obtain a carrot extract (dry solid content: 1.1%). ).

【0020】参考例3 胎盤抽出物の製造 妊娠3〜4ヶ月の牛の胎盤1kgを凍結、融解後不純物
を洗浄、除去し、精製水5リットルを加え、減圧、低温
下で3日間抽出し、濾過して胎盤抽出物を得た(乾燥固
形分3.5%)。
Reference Example 3 Production of placenta extract 1 kg of placenta of a cow of 3-4 months of pregnancy was frozen, thawed, and impurities were washed and removed, and 5 liters of purified water was added. Filtration gave a placenta extract (3.5% dry solids).

【0021】参考例4 乳酸菌発酵謝産物の製造 牛乳タンパク質水溶液1リットルに乳酸かん菌を1%接
種し、40℃で3日間培養する。得られた発酵乳を80
℃で瞬間殺菌し、濾過して乳酸菌発酵謝産物を得た(乾
燥固形分9.5%)。
Reference Example 4 Production of Fermentation Product of Lactic Acid Bacteria 1% of a milk protein aqueous solution was inoculated with 1% of a lactic acid bacterium and cultured at 40 ° C. for 3 days. 80 of the obtained fermented milk
The solution was flash sterilized at ℃ and filtered to obtain a lactic acid bacteria fermentation product (dry solid content: 9.5%).

【0022】参考例5 オウバク抽出物の製造 オウバクの全草10gを細切し、無水エタノール100
mlを加え、時々撹拌しながら室温で3日間抽出し、濾
過してオウバク抽出物を得た(乾燥固形分1.0%)。
REFERENCE EXAMPLE 5 Production of oak extract
Then, the mixture was extracted at room temperature for 3 days with occasional stirring, and filtered to obtain an oak extract (dry solid content: 1.0%).

【0023】試験例1 線維芽細胞増殖試験 シャーレに培地を適量採り、ヒト新生児線維芽細胞を播
種して、37℃、二酸化炭素濃度5%中にて静置する。
翌日、凍結乾燥した表1に示す各細胞賦活剤を濃度が1
0mg/ml、カムカム抽出物を100mg/mlとな
るようにPBS(リン酸緩衝液)に溶解し、培地の1/
10量をシャーレに添加混和する。対照として、PBS
を添加する。各試料に対する細胞数(A)及び対照の細
胞数(B)を測定し、数1により細胞増殖率を算出し
た。以上の結果を表1に示す。
Test Example 1 Fibroblast Proliferation Test An appropriate amount of medium was taken in a petri dish, and human neonatal fibroblasts were inoculated and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5%.
On the next day, each of the freeze-dried cell activators shown in Table 1 was used at a concentration of 1%.
0 mg / ml, and the camcam extract was dissolved in PBS (phosphate buffer) to 100 mg / ml, and 1/100 of the medium.
Add 10 volumes to a Petri dish and mix. As a control, PBS
Is added. The number of cells (A) and the number of control cells (B) for each sample were measured, and the cell growth rate was calculated according to Equation 1. Table 1 shows the above results.

【0024】[0024]

【数1】 (Equation 1)

【0025】[0025]

【表1】 [Table 1]

【0026】表1の結果から明らかな如く、カムカム抽
出物と細胞賦活剤のニンジン抽出物及び胎盤抽出物とを
組合わせることにより、非常に高い細胞増殖促進効果が
得られた。
As is evident from the results in Table 1, a very high cell proliferation promoting effect was obtained by combining the cam cam extract with the carrot extract and the placenta extract as cell activators.

【0027】実施例1〜3及び比較例1〜4:乳液 表2に示す組成の乳液を調製し、その皮膚老化防止効果
を調べた。その結果を併せて表2に示す。
Examples 1 to 3 and Comparative Examples 1 to 4: Emulsions Emulsions having the compositions shown in Table 2 were prepared, and the effects of preventing skin aging were examined. Table 2 also shows the results.

【0028】(組成及び結果)(Composition and results)

【表2】 [Table 2]

【0029】(製法) A.成分(14)の一部と(6)、(11)を加熱混合
し、70℃に保つ。 B.成分(1)〜(5)を加熱混合し、70℃に保つ。 C.BをAに加えて均一に乳化後、30℃まで冷却し
て、成分(10)、(12)及び(13)を加え、均一
に混合する。 D.成分(14)の残分に成分(7)〜(9)を混合
し、Cに加え、均一に混合し乳液を得た。
(Production method) A part of the component (14) and (6) and (11) are mixed by heating and maintained at 70 ° C. B. The components (1) to (5) are mixed by heating and kept at 70 ° C. C. Add B to A, emulsify uniformly, cool to 30 ° C., add components (10), (12) and (13) and mix uniformly. D. The components (7) to (9) were mixed with the residue of the component (14), added to C, and uniformly mixed to obtain an emulsion.

【0030】(試験方法)被験乳液1品につき26〜5
0才の女性15名をパネルとし、毎日、朝と夜の2回、
12週間にわたって洗顔後に被験乳液の適量を顔面に塗
布した。塗布による皮膚老化防止効果を以下の基準によ
って評価した。
(Test method) 26 to 5 per test emulsion
A panel of 15 0-year-old women, twice daily, morning and night,
After washing the face for 12 weeks, an appropriate amount of the test emulsion was applied to the face. The skin aging prevention effect of the application was evaluated according to the following criteria.

【0031】皮膚老化防止効果: [評価] [内 容] 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。 上記評価方法により得られた結果を表2に併せて示す。Skin aging prevention effect: [Evaluation] [Contents] Effective Skin peeling and gloss were improved. Slightly effective Skin glue, gloss slightly improved. Ineffective No change from before use. The results obtained by the above evaluation method are also shown in Table 2.

【0032】表2の結果から明らかな如く、本発明品に
係わるカムカム抽出物と細胞賦活剤とを配合した乳液
は、皮膚に適用することにより、肌のはり、つやが改善
され、皮膚の老化を防止することが明らかとなった。
As is evident from the results in Table 2, the emulsion containing the camcam extract and the cell activator according to the present invention is applied to the skin to improve the skin shine and gloss and to age the skin. It was found to prevent

【0033】 実施例4. 化粧水 (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレン(20E.O.) ソルビタンモノラウリン酸エステル 1.2 (4)エチルアルコール 8.0 (5)カムカム抽出物*1 1.0 (6)オオムギ抽出物*2 1.0 (7)オウバク抽出物*3 1.0 (8)防腐剤 適量 (9)香料 適量 (10)アルカリ単純温泉水*4 50.0 (11)精製水 残量 *1 参考例1で製造したもの *2 三省製薬社製 *3 参考例5で製造したもの *4 丸善製薬社製 Embodiment 4 FIG. Lotion (Formulation) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Polyoxyethylene (20EO) Sorbitan monolaurate 1.2 (4) Ethyl Alcohol 8.0 (5) Kamcum extract * 1 1.0 (6) Barley extract * 2 1.0 (7) Oat extract * 3 1.0 (8) Preservatives appropriate amount (9) Flavors appropriate amount (10 ) Alkaline simple hot spring water * 4 50.0 (11) Remaining purified water * 1 Manufactured in Reference Example 1 * 2 Manufactured by Sansho Pharmaceutical * 3 Manufactured in Reference Example 5 * 4 Manufactured by Maruzen Pharmaceutical

【0034】(製法) A.成分(3)、(4)、(8)及び(9)を混合溶解
する。 B.成分(1)、(2)、(5)、(6)、(7)、
(10)及び(11)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
(Production method) A. Components (3), (4), (8) and (9) are mixed and dissolved. B. Components (1), (2), (5), (6), (7),
(10) and (11) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0035】実施例4は、経時安定性に優れ、皮膚に適
用することにより、肌のはり、つやが改善され、皮膚の
老化防止効果を有する化粧水であった。
Example 4 was a lotion having excellent stability over time and, when applied to the skin, improved skin abrasion and luster and had an effect of preventing skin aging.

【0036】 実施例5. 軟膏 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)トリエタノールアミン 2.0 (4)グリセリン 5.0 (5)カムカム抽出物*1 10.0 (6)イチョウ抽出物*2 1.0 (7)胎盤抽出物*3 1.0 (8)乳酸*4 1.0 (9)精製水 残量 *1 参考例1で製造したもの *2 常盤植物化学研究所社製 *3 参考例3で製造したもの *4 第一製薬社製Embodiment 5 Ointment (Prescription) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Triethanolamine 2.0 (4) Glycerin 5.0 (5) Camcam extract * 1 10.0 ( 6) Ginkgo extract * 2 1.0 (7) Placenta extract * 3 1.0 (8) Lactic acid * 4 1.0 (9) Purified water balance * 1 Produced in Reference Example 1 * 2 Tokiwa plant Manufactured by Chemical Research Laboratory * 3 Manufactured in Reference Example 3 * 4 Manufactured by Daiichi Pharmaceutical

【0037】(製法) A.成分(3)、(4)及び(9)の一部を加熱混合
し、75℃に保つ。 B.成分(1)及び(2)を加熱混合し、75℃に保
つ。 C.AをBに徐々に加える。 D.Cを冷却しながら(9)の残部で溶解した(5)〜
(8)を加え、軟膏を得た。
(Production method) A. A part of components (3), (4) and (9) are mixed by heating and kept at 75 ° C. B. Heat mix components (1) and (2) and maintain at 75 ° C. C. Add A slowly to B. D. C was dissolved in the remainder of (9) while cooling (5)-
(8) was added to obtain an ointment.

【0038】実施例5は、優れた細胞賦活効果を有する
軟膏であった。
Example 5 was an ointment having an excellent cell activating effect.

【0039】 実施例6. パック (処方) (%) (1)ポリビニルアルコール 20.0 (2)エタノール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)カムカム抽出物*1 2.0 (6)ダイズ抽出物*2 3.0 (7)貝肉抽出物*3 1.0 (8)防腐剤 適量 (9)香料 適量 (10)精製水 残量 *1 参考例1で製造したもの *2 丸善製薬社製 *3 丸善製薬社製Embodiment 6 Pack (Formulation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethanol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Camcam extract * 1 2.0 (6) Soybean extract * 2 3.0 (7) Shellfish extract * 3 1.0 (8) Suitable amount of preservative (9) Suitable amount of flavor (10) Remaining amount of purified water * 1 Produced in Reference Example 1 * 2 Maruzen * 3 Maruzen Pharmaceutical

【0040】(製法) A.成分(1)、(3)、(4)及び(10)を混合
し、70℃に加熱し、撹拌する。 B.成分(2)、(8)及び(9)を混合する。 C.BをAに加え、混合した後、冷却して(5)、
(6)、(7)を均一に分散してパックを得た。
(Production method) A. Mix components (1), (3), (4) and (10), heat to 70 ° C. and stir. B. Mix components (2), (8) and (9). C. B is added to A, mixed and cooled (5),
(6) and (7) were uniformly dispersed to obtain a pack.

【0041】実施例6は、細胞賦活効果に優れ、肌への
弾力性を附与するパックであった。
Example 6 was a pack having an excellent cell activating effect and imparting elasticity to the skin.

【0042】 実施例7. 洗浄料 (処方) (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 適量 (8)防腐剤 適量 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)カムカム抽出物*1 0.5 (12)ブナの芽抽出物*2 5.0 (13)精製水 残量 *1 参考例1で製造したもの *2 GATTEFOSSE社製Embodiment 7 Detergent (Prescription) (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) Oleyl alcohol 1.5 (6) ) Purified lanolin 1.0 (7) Perfume proper amount (8) Preservative proper amount (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Camcam extract * 1 0.5 (12) Beech bud Extract * 2 5.0 (13) Remaining amount of purified water * 1 Manufactured in Reference Example 1 * 2 Manufactured by GATTEFOSSE

【0043】(製法) A.成分(9)、(10)及び(13)を混合し、70
℃に加熱する。 B.成分(1)〜(6)及び(8)を混合し、70℃に
加熱する。 C.BをAに加え、しばらく70℃に保ち、混合後、5
0℃まで冷却し、成分(7)、(11)及び(12)を
加え、冷却して洗浄料を得た。
(Production method) Mix components (9), (10) and (13) and mix
Heat to ° C. B. Mix components (1)-(6) and (8) and heat to 70 ° C. C. B is added to A, kept at 70 ° C. for a while,
After cooling to 0 ° C., components (7), (11) and (12) were added, and the mixture was cooled to obtain a detergent.

【0044】実施例7は、洗浄後の肌にはりやつやを付
与する洗浄料であった。
Example 7 was a cleaning agent for imparting a shine and shine to the washed skin.

【0045】 実施例8. 口紅 (処方) (%) (1)カムカム抽出物*1 0.02 (2)γ−リノレン酸*2 0.02 (3)乳酸菌醗酵代謝産物*3 0.01 (4)赤色202 0.2 (5)キャンデリラロウ 9.0 (6)固形パラフィン 8.0 (7)ミツロウ 5.0 (8)カルナウバロウ 5.0 (9)ラノリン 11.0 (10)イソプロピルミリステート 10.0 (11)パルミチン酸レチノール*4 1.0 (12)精製ヒマシ油 残量 (13)香料 適量 *1 参考例1で製造したもの *2 和光純薬社製 *3 参考例4で製造したもの *4 日本ロシュ社製Embodiment 8 FIG. Lipstick (Prescription) (%) (1) Camcam extract * 1 0.02 (2) γ-linolenic acid * 2 0.02 (3) Lactic acid bacteria fermentation metabolite * 3 0.01 (4) Red 202 0.2 (5) Candelilla wax 9.0 (6) Solid paraffin 8.0 (7) Beeswax 5.0 (8) Carnauba wax 5.0 (9) Lanolin 11.0 (10) Isopropyl myristate 10.0 (11) Retinol palmitate * 4 1.0 (12) Refined castor oil Remaining (13) Perfume suitable amount * 1 Manufactured in Reference Example 1 * 2 Wako Pure Chemical Industries * 3 Manufactured in Reference Example 4 * 4 Nippon Roche Company

【0046】(製法) A.成分(5)〜(10)及び(12)を加熱溶解後、
ローラーで練る。 B.Aに成分(1)〜(3)及び(4)、(11)、
(13)を加えた後、再びローラーで練る。 C.Bを冷却・成型して口紅を得た。
(Production method) After heating and dissolving the components (5) to (10) and (12),
Knead with a roller. B. In A, components (1) to (3) and (4), (11),
After adding (13), knead again with a roller. C. B was cooled and molded to obtain a lipstick.

【0047】実施例8は、口唇に、良好なつや、はりを
もたらす口紅であった。
Example 8 was a lipstick that gave a good gloss and a lip to the lips.

【0048】[0048]

【発明の効果】以上記述したように、カムカム抽出物と
細胞賦活剤とを組み合わせることにより、細胞賦活剤の
本来有する効能を十分に発揮させることができる。すな
わち、安定で且つ優れた皮膚老化防止作用を有するた
め、皮膚のはりやつやを維持し、シワ形成に高い抑制効
果を発揮するものである。従って、本発明の皮膚外用剤
は、細胞賦活剤の本来有する効果を十分発揮させること
ができるため、美容や医療において極めて有用なもので
ある。
As described above, by combining the cam cam extract with the cell activator, the original effect of the cell activator can be sufficiently exhibited. That is, since it has a stable and excellent anti-aging effect on the skin, it maintains the abrasion and luster of the skin and exerts a high inhibitory effect on wrinkle formation. Therefore, since the skin external preparation of the present invention can sufficiently exhibit the inherent effects of the cell activator, it is extremely useful in beauty and medicine.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA032 AA071 AA072 AA082 AA111 AA112 AA121 AA122 AA162 AB032 AB442 AC012 AC022 AC072 AC082 AC102 AC122 AC182 AC242 AC301 AC352 AC432 AC442 AC471 AC542 AC792 AC851 AD112 AD352 AD411 AD412 AD451 AD491 AD492 AD512 AD551 AD552 AD601 AD602 AD621 AD622 AD631 AD641 BB51 CC02 CC04 CC07 CC13 CC23 DD22 DD23 DD27 EE06 EE07 EE12 FF05 FF06  ────────────────────────────────────────────────── ─── Continued on the front page F term (reference) 4C083 AA032 AA071 AA072 AA082 AA111 AA112 AA121 AA122 AA162 AB032 AB442 AC012 AC022 AC072 AC082 AC102 AC122 AC182 AC242 AC301 AC352 AC432 AC442 AC471 AC542 AC792 AC851 AD112 AD512 AD412 AD412 AD492 AD601 AD602 AD621 AD622 AD631 AD641 BB51 CC02 CC04 CC07 CC13 CC23 DD22 DD23 DD27 EE06 EE07 EE12 FF05 FF06

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 次の成分(A)及び(B) (A)カムカム抽出物 (B)細胞賦活剤 を含有することを特徴とする皮膚外用剤。1. An external preparation for skin comprising the following components (A) and (B): (A) a camcam extract; and (B) a cell activator. 【請求項2】 細胞賦活剤が、ブドウ種子油、デオキシ
リボ核酸及びその誘導体、アデニル酸誘導体、リボ核酸
及びその誘導体、サイクリックAMP、サイクリックG
MP、フラビンアデニンジヌクレオチド、グアニン、ア
デニン、シトシン、チミン、キサンチン及びその誘導
体、ビタミンA及びその誘導体、ビタミンB及びその誘
導体、ビタミンC及びその誘導体、α−及びγ− リノ
レン酸及びそれらの誘導体、エイコサペンタエン酸及び
その誘導体、エストラジオール及びその誘導体、グリコ
ール酸、コハク酸、乳酸、サリチル酸から選ばれる有機
酸及びそれらの誘導体から選ばれたものである請求項1
記載の皮膚外用剤。
2. The cell activator is grape seed oil, deoxyribonucleic acid and its derivatives, adenylic acid derivatives, ribonucleic acids and its derivatives, cyclic AMP, cyclic G
MP, flavin adenine dinucleotide, guanine, adenine, cytosine, thymine, xanthine and its derivatives, vitamin A and its derivatives, vitamin B and its derivatives, vitamin C and its derivatives, α- and γ-linolenic acid and their derivatives, 2. An organic acid selected from eicosapentaenoic acid and its derivative, estradiol and its derivative, glycolic acid, succinic acid, lactic acid, and salicylic acid, and a derivative thereof.
The topical skin preparation according to the above.
【請求項3】 細胞賦活剤の含有量が、0.0001〜
5重量%である請求項2記載の皮膚外用剤。
3. The cell activator content is from 0.0001 to 0.0001.
The external preparation for skin according to claim 2, which is 5% by weight.
【請求項4】 細胞賦活剤が、胎盤抽出物、幼牛血液抽
出物、血清除蛋白抽出物、脾臓抽出物、卵成分、鶏冠抽
出物、貝殻抽出物、貝肉抽出物、ローヤルゼリー、シル
クプロテイン及びその分解物又はそれらの誘導体、ヘモ
グロビン又はその分解物、ラクトフェリン又はその分解
物、軟体動物抽出物、魚肉抽出物、発酵代謝産物、アス
パラガス抽出物、アンズ抽出物、イチョウ抽出物、オオ
ムギ抽出物、オウバク抽出物、オレンジ抽出物、キュウ
リ抽出物、キウイ抽出物、シイタケ抽出物、スギナ抽出
物、センブリ抽出物、ダイズ抽出物、タイソウ抽出物、
トウキンセンカ抽出物、トウガラシ抽出物、ニンニク抽
出物、ニンジン抽出物、ブクリョウ抽出物、ブナの芽抽
出物、モモ抽出物、レタス抽出物、レモン抽出物、ユー
カリ抽出物、ユリ球根抽出物、ローズマリー抽出物、ヒ
ノキチオール、セファランチン、霊芝抽出物から選ばれ
たものである請求項1記載の皮膚外用剤。
4. The cell activator is a placenta extract, a calf blood extract, a serum deproteinized extract, a spleen extract, an egg component, a cockscomb extract, a shell extract, a shell meat extract, a royal jelly, a silk protein. And its decomposition products or derivatives thereof, hemoglobin or its decomposition products, lactoferrin or its decomposition products, mollusc extracts, fish meat extracts, fermentation metabolites, asparagus extracts, apricot extracts, ginkgo extracts, barley extracts , Oak extract, orange extract, cucumber extract, kiwi extract, shiitake extract, horsetail extract, assembly extract, soybean extract, syrup extract,
Calendula extract, Capsicum extract, Garlic extract, Carrot extract, Bulberry extract, Beech bud extract, Peach extract, Lettuce extract, Lemon extract, Eucalyptus extract, Lily bulb extract, Rosemary The external preparation for skin according to claim 1, which is selected from an extract, hinokitiol, cepharanthin, and a reishi extract.
【請求項5】 細胞賦活剤の含有量が乾燥固形分とし
て、0.0001〜5重量%である請求項4記載の皮膚
外用剤。
5. The external preparation for skin according to claim 4, wherein the content of the cell activator is 0.0001 to 5% by weight as a dry solid content.
【請求項6】 カムカム抽出物の含有量が乾燥固形分と
して、0.0001〜5重量%である請求項1〜5のい
ずれか1項に記載の皮膚外用剤。
6. The skin external preparation according to any one of claims 1 to 5, wherein the content of the camcam extract is 0.0001 to 5% by weight as a dry solid content.
JP11139207A 1999-05-19 1999-05-19 Skin preparation for external use Pending JP2000327525A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11139207A JP2000327525A (en) 1999-05-19 1999-05-19 Skin preparation for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11139207A JP2000327525A (en) 1999-05-19 1999-05-19 Skin preparation for external use

Publications (1)

Publication Number Publication Date
JP2000327525A true JP2000327525A (en) 2000-11-28

Family

ID=15240044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11139207A Pending JP2000327525A (en) 1999-05-19 1999-05-19 Skin preparation for external use

Country Status (1)

Country Link
JP (1) JP2000327525A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002138013A (en) * 2000-10-27 2002-05-14 Pias Arise Kk Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use
JP2002179549A (en) * 2000-12-12 2002-06-26 Kishohin Kagaku Kaiho Kenkyusho:Kk Skin care preparation
JP2003012495A (en) * 2001-07-06 2003-01-15 Kanebo Ltd Cosmetic
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
JP2011241228A (en) * 2011-08-23 2011-12-01 Kishohin Kagaku Kaiho Kenkyusho:Kk Skin preparation for external use
WO2013029634A2 (en) 2011-09-03 2013-03-07 Pharmabrand S.A. Natural antioxidant anti-influenza composition
JP2016193846A (en) * 2015-03-31 2016-11-17 株式会社東洋新薬 Protease activity promoting matter
US10130673B2 (en) 2006-01-19 2018-11-20 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
CN113662177A (en) * 2021-08-20 2021-11-19 孙和平 Dark green tea yeast peptide group and preparation method thereof

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002138013A (en) * 2000-10-27 2002-05-14 Pias Arise Kk Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use
JP2002179549A (en) * 2000-12-12 2002-06-26 Kishohin Kagaku Kaiho Kenkyusho:Kk Skin care preparation
JP2003012495A (en) * 2001-07-06 2003-01-15 Kanebo Ltd Cosmetic
US10130673B2 (en) 2006-01-19 2018-11-20 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10918591B2 (en) 2006-01-19 2021-02-16 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US10675323B2 (en) 2006-01-19 2020-06-09 Mary Kay Inc. Topical compositions comprising acai berry extract
US10668124B2 (en) 2006-01-19 2020-06-02 Mary Kay Inc. Compositions comprising kakadu plum extract or acai berry extract
US8691300B2 (en) 2009-08-28 2014-04-08 Mary Kay Inc. Skin care formulations
US11596813B2 (en) 2009-08-28 2023-03-07 Mary Kay Inc. Skin care formulations
US9833642B2 (en) 2009-08-28 2017-12-05 Mary Kay Inc. Skin care formulations
US8895082B2 (en) 2009-08-28 2014-11-25 Mary Kay Inc. Skin care formulations
US10434340B2 (en) 2009-08-28 2019-10-08 Mary Kay Inc. Skin care formulations
US11123578B2 (en) 2009-08-28 2021-09-21 Mary Kay Inc. Skin care formulations
US11679284B2 (en) 2009-08-28 2023-06-20 Mary Kay Inc. Skin care formulations
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
JP2011241228A (en) * 2011-08-23 2011-12-01 Kishohin Kagaku Kaiho Kenkyusho:Kk Skin preparation for external use
WO2013029634A2 (en) 2011-09-03 2013-03-07 Pharmabrand S.A. Natural antioxidant anti-influenza composition
JP2016193846A (en) * 2015-03-31 2016-11-17 株式会社東洋新薬 Protease activity promoting matter
CN113662177A (en) * 2021-08-20 2021-11-19 孙和平 Dark green tea yeast peptide group and preparation method thereof

Similar Documents

Publication Publication Date Title
JP2000212027A (en) Preparation for external use for skin
JP2000229827A (en) Skin lotion
JP2000119156A (en) Skin lotion
JP2000327552A (en) Skin preparation for external use
JPH10182412A (en) External-use medical preparation
JPS61289016A (en) Skin external agent
JP2002212052A (en) External preparation
JP2001031580A (en) Preparation for external use for skin
JP2001031558A (en) Skin lotion
JP2000327525A (en) Skin preparation for external use
JP2000256131A (en) Tyrosinase production inhibitor and skin lotion containing the same
JP2000327550A (en) Skin preparation for external use
JP2002212087A (en) Skin care preparation
JP2002265313A (en) Skin care preparation
JP2003063925A (en) Skin care preparation
JP2000212026A (en) Preparation for external use for skin
JPH02292215A (en) External remedy and its usage
JP2002332224A (en) Anti-ageing skin care preparation and anti-ageing skin care preparation composition
JPH10182411A (en) Preparation for external use for skin
JP2002138027A (en) Skin care preparation for external use
JP2002275018A (en) Skin care preparation
JP3513871B2 (en) Skin whitening external preparation
JP4713032B2 (en) Skin preparation
JP2002275081A (en) Skin care preparation
JPH04321615A (en) Skin medicine for external use

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060412

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090602

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091201